Brief: InMed Pharmaceuticals Says Receives Nasdaq Notification Regarding Minimum Bid Price Compliance

Mentari Therapeutics

13/07/2022 04:34

July 12 (Reuters) - InMed Pharmaceuticals:
    * INMED PHARMACEUTICALS RECEIVES NASDAQ NOTIFICATION
REGARDING
MINIMUM BID PRICE COMPLIANCE

Source text for Eikon:  ID:nGNX8D1mZd 
Further company coverage:  INM.O 

 ((reuters.briefs@thomsonreuters.com;))